Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Onconetix (ONCO) EBT Margin (2023 - 2025)

Onconetix (ONCO) has disclosed EBT Margin for 2 consecutive years, with 11528.93% as the latest value for Q4 2024.

  • On a quarterly basis, EBT Margin fell 2322337.0% to 11528.93% in Q4 2024 year-over-year; TTM through Dec 2024 was 47.83%, a 640163.0% decrease, with the full-year FY2024 number at 85.63%, up 6355368.0% from a year prior.
  • EBT Margin was 11528.93% for Q4 2024 at Onconetix, down from 954.58% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 11694.45% in Q4 2023 to a low of 176262.79% in Q1 2023.